Anavex Life Sciences Corp (AVXL)

[falconer66a]

Results of the Alzheimer’s prophylaxis trial.

Yes such a trial [to demonstrate blarcamesine prophylaxis of Alzheimer’s] will definitely have to be large and long enough that statistics have it that a certain percentage of the enrolled at risk people would have developed AD absent the prevention.

Consider, however, what else such a trial is likely to reveal. Not only will the frequency and severity of Alzheimer’s be dramatically reduced, but the other health benefits of blarcamesine will reveal themselves; better generalized health. Specifically, reduction of the aging process, with a multitude of good outcomes.

As previously conjectured (by Drs. Missling and Hagerman and me), blarcamesine will be prescribed, to be taken daily, by everyone starting in the mid-40s.